Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components

Vox Sanguinis

Volumn 105, Issue 4, 2013, Pages 334-340

  Xiao, W ^a,b   Tormey, C A ^c,d   Capetillo, A ^a   Maitta, R W ^a,b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic reactions; Platelets; Pooled platelets; Single donor platelets; Transfusion

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLERGIC REACTION; ALLERGIC TRANSFUSION REACTION; APHERESIS; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION REACTION; CHILD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTE; THROMBOCYTE TRANSFUSION;

ALLERGIC REACTIONS; PLATELETS; POOLED PLATELETS; SINGLE-DONOR PLATELETS; TRANSFUSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD DONORS; BLOOD GROUP INCOMPATIBILITY; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERSENSITIVITY; INFANT; MALE; MIDDLE AGED; PLATELET COUNT; PLATELET TRANSFUSION; PLATELETPHERESIS; YOUNG ADULT;

EID: 84885471361     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/vox.12063     Document Type: Article

References (36)

1. Slichter SJ: Evidence-based platelet transfusion guidelines. Hematology Am Soc Hematol Educ Program 2007; 2007:172-178
2. Slichter SJ, Kaufman RM, Assmann SF, et al.: Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010; 362:600-613
3. Chambers LA, Herman JH: Considerations in the selection of a platelet component: apheresis versus whole blood-derived. Transfus Med Rev 1999; 13:311-322
4. Ness PM, Campbell-Lee SA: Single donor versus pooled random donor platelet concentrates. Curr Opin Hematol 2001; 8:392-396
5. Arnold DM, Heddle NM, Kulczycky M, et al.: In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers. Transfusion 2006; 46:257-264
6. Gurkan E, Patah PA, Saliba RM, et al.: Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40:461-464
7. Slichter SJ: Algorithm for managing the platelet refractory patient. J Clin Apher 1997; 12:4-9
8. Vamvakas EC: Relative safety of pooled whole blood-derived versus single-donor (apheresis) platelets in the United States: a systematic review of disparate risks. Transfusion 2009; 49:2743-2758
9. Ness P, Braine H, King K, et al.: Single-donor platelets reduce the risk of septic platelet transfusion reactions. Transfusion 2001; 41:857-861
10. Tormey CA, Sweeney JD, Champion MH, et al.: Analysis of transfusion reactions associated with prestorage-pooled platelet components. Transfusion 2009; 49:1242-1247
11. Wang RR, Triulzi DJ, Qu L: Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets. Am J Clin Pathol 2012; 138:255-259
12. Semple E, Bowes-Schmidt A, Yi QL, et al.: Transfusion reactions: a comparative observational study of blood components produced before and after implementation of semiautomated production from whole blood. Transfusion 2012; 52:2683-2691
13. Vassallo RR, Murphy S: A critical comparison of platelet preparation methods. Curr Opin Hematol 2006; 13:323-330
14. Andreu G, Vasse J, Herve F, et al.: Introduction of platelet additive solutions in transfusion practice. Advantages, disadvantages and benefit for patients. Transfus Clin Biol 2007; 14:100-106
15. Andreu G, Vasse J, Sandid I, et al.: Use of random versus apheresis platelet concentrates. Transfus Clin Biol 2007; 14:514-521
16. Savage WJ, Savage JH, Tobian AA, et al.: Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions. Transfusion 2012; 52:575-581
17. Savage WJ, Tobian AA, Savage JH, et al.: Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets. Transfusion 2011; 51:2337-2342
18. Hirayama F: Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. Br J Haematol 2013; 160:434-444
19. Savage WJ, Tobian AA, Fuller AK, et al.: Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion 2011; 51:1716-1722
20. Azuma H, Yamaguchi M, Takahashi D, et al.: Elevated Ca(2)+ influx-inducing activity toward mast cells in pretransfusion sera from patients who developed transfusion-related adverse reactions. Transfusion 2009; 49:1754-1761
21. Kluter H, Bubel S, Kirchner H, et al.: Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Transfusion 1999; 39:1179-1184
22. Wakamoto S, Fujihara M, Kuzuma K, et al.: Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion 2003; 43:1038-1046
23. Tobian AA, Savage WJ, Tisch DJ, et al.: Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011; 51:1676-1683
24. Sandler SG, Eckrich R, Malamut D, et al.: Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions. Blood 1994; 84:2031-2035
25. Vassallo RR: Review: IgA anaphylactic transfusion reactions. Part I. Laboratory diagnosis, incidence, and supply of IgA-deficient products. Immunohematology 2004; 20:226-233
26. Shimada E, Tadokoro K, Watanabe Y, et al.: Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies. Transfusion 2002; 42:766-773
27. Johansson SG, Nopp A, van Hage M, et al.: Passive IgE-sensitization by blood transfusion. Allergy 2005; 60:1192-1199
28. Vamvakas EC: A patient-centric approach to preventing allergic reactions to platelet transfusions. Transfusion 2011; 51:1651-1653
29. Veeraputhiran M, Ware J, Dent J, et al.: A comparison of washed and volume-reduced platelets with respect to platelet activation, aggregation, and plasma protein removal. Transfusion 2011; 51:1030-1036
30. Pruss A, Kalus U, Radtke H, et al.: Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Transfus Apher Sci 2004; 30:41-46
31. Paglino JC, Pomper GJ, Fisch GS, et al.: Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004; 44:16-24
32. Couban S, Carruthers J, Andreou P, et al.: Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Transfusion 2002; 42:753-758
33. Enright H, Davis K, Gernsheimer T, et al.: Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial. Transfusion 2003; 43:1545-1552
34. Sweeney JD, Kouttab NM, Holme S, et al.: Prestorage pooled whole-blood-derived leukoreduced platelets stored for seven days, preserve acceptable quality and do not show evidence of a mixed lymphocyte reaction. Transfusion 2004; 44:1212-1219
35. Sadani DT, Urbaniak SJ, Bruce M, et al.: Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction. Transfus Med 2006; 16:375-379
36. Karafin MS, Blagg L, Tobian AA, et al.: ABO antibody titers are not predictive of hemolytic reactions due to plasma-incompatible platelet transfusions. Transfusion 2012; 52:2087-2093